PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
NMD Pharma - Crunchbase Company Profile & Funding
Initiator Pharma
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
NMD Pharma
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round
Annual Report 2016 by Lundbeckfonden - issuu
Prominent Canadian researcher in Denmark: Why I left a top job in California
Initiator Pharma
NMD Pharma company information, funding & investors | Dealroom.co
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB
Company Presentation
NMD Pharma company information, funding & investors | Dealroom.co
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
NMD Pharma A/S | LinkedIn
Initiator Pharma | LinkedIn
BioLeader Interview - PIR International
NMD Pharma A/S | LinkedIn
NMD Pharma
UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular Disease Mentor 1 Pontus Gourdon, MSc & PhD,
